1-year health outcomes associated with systemic corticosteroids for COVID-19: a longitudinal cohort study
Background In patients with coronavirus disease 2019 (COVID-19) requiring supplemental oxygen, dexamethasone reduces acute severity and improves survival, but longer-term effects are unknown. We hypothesised that systemic corticosteroid administration during acute COVID-19 would be associated with i...
Tallennettuna:
| Päätekijät: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
European Respiratory Society
2024-09-01
|
| Sarja: | ERJ Open Research |
| Linkit: | http://openres.ersjournals.com/content/10/5/00474-2024.full |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|
